Ginkgo Bioworks, Solvay announce strategic collaboration

Solvay announced a strategic collaboration with Ginkgo Bioworks. Through this multi-year strategic collaboration agreement, Solvay will join forces with Ginkgo to unlock the power of synthetic biology as an enabler of more sustainable chemicals and materials, contributing to the transition towards more environmentally-friendly solutions. This alliance will start by focusing on new sustainable biopolymers, specialties which could tangibly impact a breadth of markets, from home and personal care to agriculture and food. As part of this partnership, Solvay will also acquire a Ginkgo laboratory in Cambridge, Massachusetts. This acquisition will expand Solvay’s research and innovation footprint in the US, provide Solvay access to new talents, and establish a sustainable growth base in synthetic biology in one the most important biotech hubs in the world, accelerating the company’s biotech development plan. With this strategic collaboration and expansion, Solvay will integrate deep competencies in bioinformatics and data science, strain engineering, biocatalysis and fermentation processes, strengthening and accelerating the ability to scout, develop and turn into businesses the most valuable biotech-enabled opportunities.